Resonance Health LtdASX: RHT

FY26 Full Year Results & FY27 Guidance Investor Presentation

· Issued by Resonance Health Ltd via ASX

Filed with ASX · · 35 pages · English

Summary by 6ix AI

Resonance Health Ltd has released its full-year results for the fiscal year, highlighting significant revenue growth and a return to profitability. The company reported a notable increase in revenue and normalised EBITDA, reflecting strong operational performance across its three business segments.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

1 1 Andrew Harrison, CEO Benjamin Carruthers, CFO FY26 Full - Year Results August 28 th 2026 01 Why Resonance & Highlights Why Resonance - Why Now & FY26 Highlights ASX : RHT I N T H I S S E C T I O N 3 The Business 4 5 Why Resonance – Why Now 6 FY26 Highlights 2 Global...

Resonance Health Ltd on 6ix

In the deck

Story so far

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases